» Authors » Shigeru Horiguchi

Shigeru Horiguchi

Explore the profile of Shigeru Horiguchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 118
Citations 655
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kajitani S, Matsumoto K, Oki K, Matsumi A, Miyamoto K, Fujii Y, et al.
DEN Open . 2025 Mar; 5(1):e70096. PMID: 40070932
A 64-year-old woman had undergone subtotal stomach-preserving pancreaticoduodenectomy for locally advanced pancreatic head cancer. She had an uneventful postoperative course with no recurrence. However, approximately 18 months after surgery, she...
2.
Horiguchi S, Kato H, Miyamoto K, Morimoto K, Matsumi A, Terasawa H, et al.
Clin J Gastroenterol . 2025 Mar; PMID: 40032770
Intrahepatic cholangiocarcinoma has a poor prognosis. In unresectable cases, the survival period is short despite combination therapy with cytotoxic anticancer agents and immune checkpoint inhibitors. The usefulness of immune checkpoint...
3.
Sato R, Matsumoto K, Uka M, Takagi K, Nishida K, Tanaka T, et al.
Clin J Gastroenterol . 2025 Feb; PMID: 39910028
We herein report a case of pancreatic ductal adenocarcinoma (PDAC) that developed within the pancreatic duct and was initially diagnosed as an intraductal tubulopapillary neoplasm (ITPN). A 76-year-old man presented...
4.
Matsumoto K, Uchida D, Takeuchi Y, Kato H, Fujii Y, Harada K, et al.
DEN Open . 2025 Jan; 5(1):e70073. PMID: 39885893
Objectives: Endoscopic ultrasonography (EUS)-guided radiofrequency ablation has recently been introduced as one of the management strategies for small pancreatic neuroendocrine neoplasms (PNENs). However, prospective data on its safety and efficacy...
5.
Fujii Y, Uchida D, Sato R, Obata T, Akihiro M, Miyamoto K, et al.
Sci Rep . 2024 Sep; 14(1):22441. PMID: 39341885
Rapid on-site cytopathology evaluation (ROSE) has been considered an effective method to increase the diagnostic ability of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA); however, ROSE is unavailable in most institutes...
6.
Sato R, Matsumoto K, Kinugasa H, Tomiya M, Tanimoto T, Ohto A, et al.
Gastrointest Endosc . 2024 Jun; 100(5):938-946.e1. PMID: 38879044
Background And Aims: Accurately diagnosing biliary strictures is crucial for surgical decisions, and although peroral cholangioscopy (POCS) aids in visual diagnosis, diagnosing malignancies or determining lesion margins via this route...
7.
Matsumoto K, Kato H, Matsumi A, Miyamoto K, Morimoto K, Fujii Y, et al.
Gastrointest Endosc . 2024 Apr; 100(3):457-463. PMID: 38631519
Background And Aims: The difficulty in radiographic confirmation of the presence of stones remains challenging in the treatment of intrahepatic bile duct (IHBD) stones in patients after hepaticojejunostomy (HJ). Peroral...
8.
Oda T, Tsutsumi K, Obata T, Ueta E, Kikuchi T, Ako S, et al.
Mol Ther Oncol . 2024 Apr; 32(1):200765. PMID: 38596294
Gallbladder cancer incidence has been increasing globally, and it remains challenging to expect long prognosis with the current systemic chemotherapy. We identified a novel nucleic acid-mediated therapeutic target against gallbladder...
9.
Inoo S, Kono Y, Kanzaki H, Horiguchi S, Kato H, Yamasaki Y, et al.
J Geriatr Oncol . 2024 Feb; 15(4):101714. PMID: 38331689
No abstract available.
10.
Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, et al.
Mol Ther Nucleic Acids . 2023 Dec; 34:102054. PMID: 38111913
Gemcitabine is an effective chemotherapeutic agent for biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA). However, few other effective agents are currently available, particularly for GEM-refractory BTCs....